Two distinct cytokines released from a human aminoacyl-tRNA synthetase

Science

Volumn 284, Issue 5411, 1999, Pages 147-151

  Wakasugi, Keisuke ^a   Schimmel, Paul ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; CYTOKINE; TYROSINE TRANSFER RNA LIGASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

AMINO ACID SEQUENCE; ANTIGENS, CD; APOPTOSIS; BINDING, COMPETITIVE; CATALYTIC DOMAIN; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MOLECULAR SEQUENCE DATA; MONOCYTES; NEOPLASM PROTEINS; NEUTROPHILS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-8A; RECOMBINANT PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYROSINE-TRNA LIGASE;

EID: 0033515887     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5411.147     Document Type: Article

References (47)

1. M. Mirande, D. Le Corre, J.-P. Waller, Eur. J. Biochem. 147, 281 (1985); M. Mirande, Prog. Nucleic Acid Res. Mol. Biol. 40, 95 (1991).
2. M. Mirande, D. Le Corre, J.-P. Waller, Eur. J. Biochem. 147, 281 (1985); M. Mirande, Prog. Nucleic Acid Res. Mol. Biol. 40, 95 (1991).
3. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
4. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
5. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
6. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
7. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
8. C. Cerini et al., EMBO J. 10, 4267 (1991); M. Lazard and M. Mirande, Gene 132, 237 (1993); K. Shiba et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7435 (1994); S. B. Rho et al., ibid. 93, 10128 (1996); F. Agou and M. Mirande, Eur. J. Biochem. 243, 259 (1997); S. B. Rho et al., J. Biol. Chem. 273, 11267 (1998).
9. T. A. Kleeman, D. Wei, K. L. Simpson, E. A. First, J. Biol. Chem. 272, 14420 (1997).
10. A. I. Kornelyuk, I. V. Kurochkin, G. H. Matsuka, Mol. Biol. [Engl. Transl. Mol. Biol. (Mosc.)] 22, 176 (1988); A. D. Wolfson, Y. A. Motorin, T. I. Ribkinska, S. F. Beresten, J. Chromatogr. 503, 277 (1990).
11. A. I. Kornelyuk, I. V. Kurochkin, G. H. Matsuka, Mol. Biol. [Engl. Transl. Mol. Biol. (Mosc.)] 22, 176 (1988); A. D. Wolfson, Y. A. Motorin, T. I. Ribkinska, S. F. Beresten, J. Chromatogr. 503, 277 (1990).
12. Human full-length and mini TyrRSs, the extra COOH-terminal domain of human TyrRS, E. coli TyrRS, and human mature EMAP II (with a COOH-terminal tag of six histidine residues) were over-expressed in E. coli strain BL 21 (DE 3) (Novagen, Madison, WI) by induction with isopropyl β-D-thiogalactopyranoside for 4 hours. Proteins were purified on a nickel affinity column (His®Bind resin; Novagen) from the supernatant of lysed cells. Endotoxin was removed from the protein solutions by phase separation using Triton X-114 [Y. Aida and M. J. Pabst, J. Immunol. Methods 132, 191 (1990); S. Liu et al., Clin. Biochem. 30, 455 (1997).] and was determined to be <0.01 endotoxin units per milliliter by a Limulus Amebocyte Lysate gel-clot assay (E-Toxate; Sigma, St. Louis, MO).
13. Human full-length and mini TyrRSs, the extra COOH-terminal domain of human TyrRS, E. coli TyrRS, and human mature EMAP II (with a COOH-terminal tag of six histidine residues) were over-expressed in E. coli strain BL 21 (DE 3) (Novagen, Madison, WI) by induction with isopropyl β-D-thiogalactopyranoside for 4 hours. Proteins were purified on a nickel affinity column (His®Bind resin; Novagen) from the supernatant of lysed cells. Endotoxin was removed from the protein solutions by phase separation using Triton X-114 [Y. Aida and M. J. Pabst, J. Immunol. Methods 132, 191 (1990); S. Liu et al., Clin. Biochem. 30, 455 (1997).] and was determined to be <0.01 endotoxin units per milliliter by a Limulus Amebocyte Lysate gel-clot assay (E-Toxate; Sigma, St. Louis, MO).
14. K. Wakasugi, C. L. Quinn, N. Tao, P. Schimmel, EMBO J. 17, 297 (1998).
15. K. Wakasugi and P. Schimmel, unpublished observations, [supplementary data can be found at the Science Web site (www.sciencemag.org/feature/data/ 990263.shl)]
16. J. Kao et al., J. Biol. Chem. 267, 20239 (1992); J. Kao et al., ibid. 269, 9774 (1994); J. Kao et al., ibid., p. 25106.
17. J. Kao et al., J. Biol. Chem. 267, 20239 (1992); J. Kao et al., ibid. 269, 9774 (1994); J. Kao et al., ibid., p. 25106.
18. J. Kao et al., J. Biol. Chem. 267, 20239 (1992); J. Kao et al., ibid. 269, 9774 (1994); J. Kao et al., ibid., p. 25106.
19. M. P. R. Tas et al., Cytokine 9, 535 (1997).
20. Human MPs and PMNs were prepared from acid citrate dextrose - treated:blood of normal healthy volunteers (8).
21. T. J. Daly et al., J. Biol. Chem. 270, 23282 (1995).
22. E. L. Becker, Arch. Pathol. Lab. Med. 101, 509 (1977).
23. M. Baggiolini and I. Clark-Lewis, FEBS Lett. 307, 97 (1992); R. C. Hoch, I. U. Schraufstätter, C. G. Cochrane, J. Lab. Clin. Med. 128, 134 (1996); M. Baggiolini, B. Dewald, B. Moser, Annu. Rev. Immunol. 15, 675 (1997).
24. M. Baggiolini and I. Clark-Lewis, FEBS Lett. 307, 97 (1992); R. C. Hoch, I. U. Schraufstätter, C. G. Cochrane, J. Lab. Clin. Med. 128, 134 (1996); M. Baggiolini, B. Dewald, B. Moser, Annu. Rev. Immunol. 15, 675 (1997).
25. M. Baggiolini and I. Clark-Lewis, FEBS Lett. 307, 97 (1992); R. C. Hoch, I. U. Schraufstätter, C. G. Cochrane, J. Lab. Clin. Med. 128, 134 (1996); M. Baggiolini, B. Dewald, B. Moser, Annu. Rev. Immunol. 15, 675 (1997).
26. C. A. Hébert, R. V. Vitangcol, J. B. Baker, J. Biol. Chem. 266, 18989 (1991); I. Clark-Lewis, C. Schumacher, M. Baggiolini, B. Moser, ibid., p. 23128; B. Moser et al., ibid. 268, 7125 (1993).
27. C. A. Hébert, R. V. Vitangcol, J. B. Baker, J. Biol. Chem. 266, 18989 (1991); I. Clark-Lewis, C. Schumacher, M. Baggiolini, B. Moser, ibid., p. 23128; B. Moser et al., ibid. 268, 7125 (1993).
28. C. A. Hébert, R. V. Vitangcol, J. B. Baker, J. Biol. Chem. 266, 18989 (1991); I. Clark-Lewis, C. Schumacher, M. Baggiolini, B. Moser, ibid., p. 23128; B. Moser et al., ibid. 268, 7125 (1993).
29. 125I was performed by Research & Diagnostic Antibody (Richmond, CA).
30. 125I-human mini TyrRS (specific activity of ∼60 Ci/ mmol) in the absence or presence of a 200-fold molar excess of either unlabeled TyrRSs, human mature EMAP II, human recombinant IL-8 (Calbiochem, La Jolla, CA), human recombinant Groα (Biosource International, Camaritlo, CA), or human recombinant NAP-2 (Biosource International). Cells were separated from unbound radioactivity by centrifugation at approximately 8000g for 2 min through 500 μl of a 10% sucrose/phosphate-buffered saline (PBS) cushion. The supernatant was aspirated, and the cell sediment was resuspended by using Ecolite (ICN Biomedicals, Irvine, CA) and analyzed in a scintillation counter.
31. 125I-human mini TyrRS (specific activity of ∼60 Ci/ mmol) in the absence or presence of a 200-fold molar excess of either unlabeled TyrRSs, human mature EMAP II, human recombinant IL-8 (Calbiochem, La Jolla, CA), human recombinant Groα (Biosource International, Camaritlo, CA), or human recombinant NAP-2 (Biosource International). Cells were separated from unbound radioactivity by centrifugation at approximately 8000g for 2 min through 500 μl of a 10% sucrose/phosphate-buffered saline (PBS) cushion. The supernatant was aspirated, and the cell sediment was resuspended by using Ecolite (ICN Biomedicals, Irvine, CA) and analyzed in a scintillation counter.
32. J. Lee et al., J. Biol. Chem. 267, 16283 (1992).
33. I. U. Schraufstätter, M. Burger, R. C. Hoch, Z. G. Oades, H. Takamori, Biochem. Biophys. Res. Commun. 244, 243 (1998).
34. L. Ghibelli, S. Coppola, C. Nosseri, A. Bergamini, S. Beninati, FEBS Lett. 344, 35 (1994).
35. 6 cells) were cultured in RPMI 1640 medium without or with heat-treated fetal bovine serum (10%). Cells were washed twice with ice-cold PBS, and resuspended in lysis buffer containing 25 mM Hepes (pH 7.5), 5 mM EDTA, 5 mM dithiothreitol, 0.1% CHAPS detergent, 2 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml aprotinin, 20 μg/ml leupeptin, and 10 μg/ml pepstatin A. The cells were frozen and thawed three times in liquid nitrogen, and then centrifuged for 30 min at 4°C. For examination of proteins in the cell supernatant, 20 ml of spent culture medium (to which the following protease inhibitors were added: 2 mM PMSF, 10 μg/ml aprotinin, 20 μg/ml leupeptin, and 10 μg/ml pepstatin A) was concentrated in a Centriprep-10 (Amicon, Beverly, MA), and the samples were then analyzed on 12.5% SDS-polyacrylamide gels. After transfer onto Immobilon-P transfer membrane (Millipore, Bedford, MA), the membranes were blocked with PBS and 3% BSA, and incubated with rabbit polyclonal antibodies against human full-length TyrRS. Washed membranes were then incubated with a horseradish peroxidase-linked antibody to rabbit immunoglobulin (1:4000 dilution; Amersham Life Science, Arlington Heights, IL) for detection of TyrRS.
36. LDH activities were determined spectrophotometrically with a CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega, Madison, WI).
37. S. C. Wright et al., J. Cell. Biochem. 48, 344 (1992).
38. K. Bjørnland et al., Int. J. Oncol. 12, 535 (1998).
39. E. Brandt, J. Van Damme, H.-D. Flad, Cytokine 3, 311 (1991).
40. L. Ribas de Pouplana, M. Frugier, C. L. Quinn, P. Schimmel, Proc. Natl. Acad. Sci. U.S.A. 93, 166 (1996).
41. D. C. Barker, C. J. Burton, G. Winter, FEBS Lett. 150, 419 (1982).
42. R. Menegazzi, C. Zabucchi, A. Knowles, R. Cramer, P. Patriarca, J. Leukocyte Biol. 52, 619 (1992).
43. R. M. Starzyk, T. A. Webster, P. Schimmel, Science 237, 1614 (1987).
44. A. Richmond et al., EMBO J. 7, 2025 (1988).
45. A. Walz and M. Baggiolini, J. Exp. Med. 171, 449 (1990).
46. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser, T, Thr; V, Val; W, Trp; and Y, Tyr.
47. We thank I. U. Schraufstātter for RBL2H3 rat basophilic leukemia cells expressing IL-8 type A or B receptor, and D. J. Loskutoff for human U-937 cells. Supported by NIH grant GM23562 and by a grant from the National Foundation for Cancer Research. K.W. was supported by a JSPS (Japan Society for the Promotion of Science) Postdoctoral Fellowships for Research Abroad.